Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.75
+0.09 (0.54%)
At close: Jul 9, 2026, 4:00 PM EDT
16.74
-0.01 (-0.06%)
After-hours: Jul 9, 2026, 4:22 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.02 billion as of July 9, 2026. Its market cap has decreased by -26.07% in one year.
Market Cap
1.02B
Enterprise Value
77.53M
1-Year Change
-26.07%
Ranking
Category
Stock Price
$16.75
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.02B, an increase of 66.44%. That is a compound annual growth rate of 10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.02B | 23.06% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 1.08B |
| Olema Pharmaceuticals | 1.07B |
| Arbutus Biopharma | 1.03B |
| Inventiva | 1.01B |
| Pharming Group | 1.01B |
| Avalo Therapeutics | 1.01B |
| Lexicon Pharmaceuticals | 1.01B |
| Geron | 1.00B |